Abstract
Background
Breast-conserving therapy (BCT) offers oncologic outcomes similar to those of mastectomy, yet many patients, when provided the option, choose mastectomy. This study aimed to evaluate the relationship between patient-reported distress and surgical decisions and to determine factors predictive of choosing BCT versus mastectomy.
Methods
Patients with newly diagnosed breast cancer deemed candidates for BCT who completed a distress screen at their initial visit to an academic institution between 2016 and 2019 were retrospectively reviewed. This screening tool captures distress in emotional, social, health, and practical domains on a scale of 0 to 10. The distress scores were compared against surgical decisions using nonparametric Wilcoxon rank-sum tests. Patient factors associated with surgical choice were analyzed using chi-square, Fisher’s exact, and Student’s t tests. A two-sided p value lower than 0.05 was considered significant.
Results
Of 506 patients deemed eligible for BCT, 430 (85%) chose BCT and 76 (15%) pursued mastectomy. The distress levels did not differ significantly between the surgical options. The patients who underwent mastectomy were on the average younger (50.7 vs 60.4 years; p < 0.0001), presented with palpable masses (p < 0.0001), had stage 0, 2, or 3 versus stage 1 disease (p < 0.0001), sought consultation for second opinions (19.7% vs 8.6%; p = 0.0032), received neoadjuvant chemotherapy (31.6% vs 16.3%; p = 0.0016), or had deleterious gene mutations (21.1% vs 5.1%; p < 0.0001).
Conclusions
Distress was not associated with the pursuit of surgical treatment. Rather, younger age, search for a second opinion, and a palpable mass present at presentation were associated with more aggressive surgical decisions. Understanding factors that influence surgical decision-making is critical in guiding informed decisions that reflect patient values.
Similar content being viewed by others
References
Early Breast Cancer Trialists’ Collaborative G DS, McGale, P. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet. 2011;378:1707–16.
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow up of randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.
Volders JH, Negenborn VL, Haloua MH, et al. Cosmetic outcome and quality of life are inextricably linked in breast-conserving therapy. J Surg Oncol. 2017;115:941–8.
Engel J, Kerr J, Schlesinger-Raab A, Sauer H, Hölzel D. Quality of life following breast-conserving therapy or mastectomy: results of a 5-year prospective study. Breast J. 2004;10:223–31.
Kummerow KL, Du L, Penson DF, Shyr Y, Hooks MA. Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg. 2015;150:9–16.
Mahmood U, Hanlon AL, Koshy M, et al. Increasing national mastectomy rates for the treatment of early-stage breast cancer. Ann Surg Oncol. 2013;20:1436–43.
Gu J, Delisle M, Engler-Stringer R, Groot G. Mastectomy versus breast-conservation therapy: an examination of how individual, clinicopathologic, and physician factors influence decision-making. Curr Oncol. 2019;26:e522–34.
Gu J, Groot G, Boden C, Busch A, Holtslander L, Lim H. Review of factors influencing women’s choice of mastectomy versus breast-conserving therapy in early-stage breast cancer: a systematic review. Clin Breast Cancer. 2018;18:e539–54.
Collins ED, Moore CP, Clay KF, et al. Can women with early-stage breast cancer make an informed decision for mastectomy? J Clin Oncol. 2009;27:519–25.
Bedrosian I, Yao K. Contralateral prophylactic mastectomy: anxiety, knowledge, and shared decision-making. Ann Surg Oncol. 2015;22:3767–8.
Parker PA, Peterson SK, Bedrosian I, et al. Prospective study of surgical decision-making processes for contralateral prophylactic mastectomy in women with breast cancer. Ann Surg. 2016;263:178–83.
Rosenberg SM, Sepucha K, Ruddy KJ, et al. Local therapy decision-making and contralateral prophylactic mastectomy in young women with early-stage breast cancer. Ann Surg Oncol. 2015;22:3809–15.
Ludwigson A, Huynh V, Bronsert M, et al. A screening tool identifies high distress in newly diagnosed breast cancer patients. Surgery. 2020;168:935–41.
Pitman A, Suleman S, Hyde N, Hodgkiss A. Depression and anxiety in patients with cancer. BMJ. 2018;361:k1415.
Riba MB, Donovan KA, Andersen B, et al. Distress management, Version 3.2019, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019;17(10):1229–1249.
Lam WW, Shing YT, Bonanno GA, Mancini AD, Fielding R. Distress trajectories at the first-year diagnosis of breast cancer in relation to 6 years survivorship. Psychooncology. 2012;21:90–9.
Petersen S, Schwartz RC, Sherman-Slate E, Frost H, Straub JL, Damjanov N. Relationship of depression and anxiety to cancer patients’ medical decision-making. Psychol Rep. 2003;93:323–34.
Lee WQ, Tan VKM, Choo HMC, et al. Factors influencing patient decision-making between simple mastectomy and surgical alternatives. BJS Open. 2019;3:31–7.
Minami CA, King TA, Mittendorf EA. Patient preferences for locoregional therapy in early-stage breast cancer. Breast Cancer Res Treat. 2020;183:291–309.
Rosenberg SM, Greaney ML, Patenaude AF, Partridge AH. Factors affecting surgical decisions in newly diagnosed young women with early-stage breast cancer. J Adolesc Young Adult Oncol. 2019;8:463–8.
Zikmund-Fisher BJ, Fagerlin A, Ubel PA. Risky feelings: why a 6% risk of cancer does not always feel like 6%. Patient Educ Couns. 2010;81(Suppl):S87-93.
Orom H, Underwood W III, Biddle C. Emotional distress increases the likelihood of undergoing surgery among men with localized prostate cancer. J Urol. 2017;197:350–5.
LeVasseur N, Li H, Cheung W, et al. Effects of high anxiety scores on surgical and overall treatment plan in patients with breast cancer treated with neoadjuvant therapy. Oncologist. 2019;25:212–7.
Bleicher RJ, Abrahamse P, Hawley ST, Katz SJ, Morrow M. The influence of age on the breast surgery decision-making process. Ann Surg Oncol. 2008;15:854–62.
Lokich E, Stuckey A, Raker C, Wilbur JS, Laprise J, Gass J. Preoperative genetic testing affects surgical decision making in breast cancer patients. Gynecol Oncol. 2014;134:326–30.
Yadav S, Jinna S, Pereira-Rodrigues O, et al. Impact of preoperative BRCA1/2 testing on surgical decision-making in patients with newly diagnosed breast cancer. Breast J. 2018;24:541–8.
Syrowatka A, Motulsky A, Kurteva S, et al. Predictors of distress in female breast cancer survivors: a systematic review. Breast Cancer Res Treat. 2017;165:229–45.
Storm-Dickerson T, Das L, Gabriel A, Gitlin M, Farias J, Macarios D. What drives patient choice: preferences for approaches to surgical treatments for breast cancer beyond traditional clinical benchmarks. Plast Reconstr Surg Glob Open. 2018;6:e1746.
Hillen MA, Medendorp NM, Daams JG, Smets EMA. Patient-driven second opinions in oncology: a systematic review. Oncologist. 2017;22:1197–211.
Gusic LH, Walsh K, Flippo-Morton T, Sarantou T, Boselli D, White RL Jr. Rationale for mastectomy after neoadjuvant chemotherapy. Am Surg. 2018;84:126–32.
Golshan M, Loibl S, Wong SM, et al. Breast conservation after neoadjuvant chemotherapy for triple-negative breast cancer: surgical results from the BrighTNess randomized clinical trial. JAMA Surg. 2020;155:e195410.
Reyna VF, Nelson WL, Han PK, Pignone MP. Decision-making and cancer. Am Psychol. 2015;70:105–18.
Halpern J, Arnold RM. Affective forecasting: an unrecognized challenge in making serious health decisions. J Gen Intern Med. 2008;23:1708–12.
Partridge A, Adloff K, Blood E, et al. Risk perceptions and psychosocial outcomes of women with ductal carcinoma in situ: longitudinal results from a cohort study. J Natl Cancer Inst. 2008;100:243–51.
Lee CN, Pignone MP, Deal AM, et al. Accuracy of predictions of patients with breast cancer of future well-being after immediate breast reconstruction. JAMA Surg. 2018;153:e176112.
Waljee JF, Ubel PA, Atisha DM, Hu ES, Alderman AK. The choice for breast cancer surgery: can women accurately predict postoperative quality of life and disease-related stigma? Ann Surg Oncol. 2011;18:2477–82.
Acknowledgment
This work was supported by the Health Data Compass Data Warehouse Projects (healthdatacompass.org) and the Surgical Outcomes and Applied Research (SOAR) Program, which are a collaboration between the University of Colorado Department of Surgery and the Adult and Child Consortium for Health Outcomes Research and Delivery Science (ACCORDS). This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
There are no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Huynh, V., Yang, J., Bronsert, M. et al. Choosing Between Mastectomy and Breast-Conserving Therapy: Is Patient Distress an Influencing Factor?. Ann Surg Oncol 28, 8679–8687 (2021). https://doi.org/10.1245/s10434-021-10323-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-10323-4